| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6226005 | Paediatric Respiratory Reviews | 2012 | 6 Pages | 
Abstract
												SummaryThe Long QT syndrome (LQTS) is a rare disorder in which patients are prone to life threatening ventricular arrhythmia and is a leading cause of sudden death in childhood. Asthma is common and its management in those with LQTS presents a number of potential difficulties. The mainstay of therapy in LQTS is beta-blockade, which may worsen symptoms of asthma. Conversely, beta-agonist therapy is the mainstay of asthma management; which, in those with LQTS, may provoke ventricular arrhythmias. We review available data regarding the management of coexistent LQTS and asthma, and provide a summary of the necessary considerations in managing these patients.
Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Perinatology, Pediatrics and Child Health
												
											Authors
												Samuel Collins, John Widger, Andrew Davis, John Massie, 
											